Introduction to Biopharmaceutics
Start with the big picture
This introduction distinguishes biopharmaceutics from pharmacokinetics and connects both fields to drug product performance. It introduces bioavailability as the fraction of a dose that reaches systemic circulation, and bioequivalence as a comparison of products using exposure measures. Key pharmacokinetic parameters—including Cmax, Tmax, AUC, half-life, clearance, and volume of distribution—help describe drug concentration over time. For oral medicines, absorption may be limited by dissolution or permeability. The lesson also previews how formulation and physiological factors affect absorption, how the Biopharmaceutics Classification System organizes drugs by solubility and permeability, and how dissolution, membrane transport, ionization, and in-vitro–in-vivo relationships help explain observed drug behavior.
What you'll learn
- Distinguish biopharmaceutics from pharmacokinetics and describe their relationship to ADME.
- Explain bioavailability and bioequivalence using the concepts introduced in the lesson.
- Identify key pharmacokinetic parameters and the information they provide.
- Describe dissolution- and permeability-limited absorption and relevant formulation and physiological influences.
- Recognize how BCS, drug absorption mechanisms, and IVIVC organize biopharmaceutic concepts.
Continue your study
Work through the complete notes and reinforce the topic with the study tools available in the full lesson.